| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | CA2838392A1 Chlorite in the treatment of neurodegenerative disease |
| 08/25/2005 | CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/25/2005 | CA2556400A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2556266A1 Use of luteinizing hormone (lh), and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 08/25/2005 | CA2555815A1 Dihydrotetrabenazines and pharmaceutical compositions containing them |
| 08/25/2005 | CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators |
| 08/25/2005 | CA2555099A1 Alcohol metabolism moderating composition |
| 08/25/2005 | CA2554559A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 08/25/2005 | CA2554511A1 Chlorite in the treatment of neurodegenerative disease |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/25/2005 | CA2549954A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566378A1 Isoindoline derivative |
| 08/24/2005 | EP1566184A1 Remedy for corneal failure |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1566178A1 Remedy for fibromyalgia |
| 08/24/2005 | EP1565748A2 Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565475A1 Diazinopyrimidines |
| 08/24/2005 | EP1565464A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 08/24/2005 | EP1565454A1 Pyrazine compounds as crf modulators |
| 08/24/2005 | EP1565451A1 Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| 08/24/2005 | EP1565445A1 Novel process for the preparation of imidazolyl compounds |
| 08/24/2005 | EP1565432A1 Histone deacetylase inhibitors |
| 08/24/2005 | EP1565428A1 Substituted ureas and carbamates |
| 08/24/2005 | EP1565213A2 Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 08/24/2005 | EP1565202A2 Methods for the treatment of alzheimer's disease and compositions therefore |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565190A2 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 08/24/2005 | EP1565184A1 Treatment of headache with antipsychotics delivered by inhalation |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565173A2 Composition and its use for treating neuropathic sensory loss |
| 08/24/2005 | EP1565172A2 Suppression of cytotoxic protein conformers |
| 08/24/2005 | EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations |
| 08/24/2005 | EP1565055A2 Compounds for the treatment of tobacco dependence and withdrawal |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1372624B1 Tramadol-based medicament |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors |
| 08/24/2005 | EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/24/2005 | EP1072266B1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens |
| 08/24/2005 | CN1659170A Thienyl compounds |
| 08/24/2005 | CN1659166A 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1659133A 2, 5-bis-diamine-[1, 4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658883A Methods for increasing the therapeutic response to electroconvulsive therapy |
| 08/24/2005 | CN1658879A Neurotrophic factor production accelerator |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658876A A buffered, liquid nicotine composition for pulmonary administration |
| 08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658868A Bazedoxifene treatment regimens |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658853A Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX 2) inhibitor(s) |
| 08/24/2005 | CN1658852A Amidine derivatives for treating amyloidosis |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1658846A 贴剂 Patch |
| 08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 08/24/2005 | CN1657084A Oral Chinese medicinal preparation for treating vascular dementia |
| 08/24/2005 | CN1657076A Medicinal incense possessing health-care function |
| 08/24/2005 | CN1657075A Medicine for treating depression |
| 08/24/2005 | CN1657071A Asarum brain injection and its preparation method |
| 08/24/2005 | CN1657070A Chinese medicinal composition possessing liver calming, promoting blood flow and tranquilization and its preparation mathod |